Adamastor Bioservices

Startup

Adamastor Bioservices offers a range of molecular binding assays, specializing in drug discovery for neurodegenerative, inflammatory, and infectious diseases. Their unique approach integrates in vitro and cellular interaction studies, using Surface Plasmon Resonance (SPR) for detailed molecular analyses and real-time cell binding assays (RT-CBA) for insights into live cellular environments. This dual capability provides a comprehensive understanding of drug behavior, from molecular interactions to cellular processes, enabling more accurate predictions of therapeutic efficacy. Alongside their advanced assays, Adamastor offers consulting services to help pharmaceutical and biotech companies streamline drug discovery. Their expert guidance provides strategic insights and technical support, accelerating the development of new therapies. With a commitment to scientific excellence and data-driven solutions, Adamastor empowers clients to confidently interpret results and make informed decisions in pharmaceutical advancement.